These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 6066998)
41. Effect of splenectomy on the regression of transplantable tumors. Ferrer JF; Mihich E Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442 [No Abstract] [Full Text] [Related]
42. [Search for biochemical criteria of sensitivity and resistance of tumor cells to antimetabolites]. Belousova AK; Gerasimova GK Vestn Akad Med Nauk SSSR; 1978; (5):58-64. PubMed ID: 676465 [No Abstract] [Full Text] [Related]
43. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS. BOOTH BA; SARTORELLI AC Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870 [No Abstract] [Full Text] [Related]
44. [Cytostatic-testing with the particle counter TuR ZG 1]. Gutsche W Arzneimittelforschung; 1968 Feb; 18(2):258-9. PubMed ID: 5695392 [No Abstract] [Full Text] [Related]
45. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil. Sartorelli AC; Booth BA Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069 [No Abstract] [Full Text] [Related]
46. The carcinostatic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone. Blanz EJ; French FA Cancer Res; 1968 Dec; 28(12):2419-22. PubMed ID: 5728150 [No Abstract] [Full Text] [Related]
47. Studies on water-soluble antitumor antibiotics produced by Streptomyces sp., No. OS-786. Iwai Y; Komiyama K; Oiwa R; Awaya J; Umezawa I Kitasato Arch Exp Med; 1971 Jun; 44(2):95-105. PubMed ID: 5148026 [No Abstract] [Full Text] [Related]
48. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA). Prince HN; Grunberg E; Buck M; Cleeland R Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347 [No Abstract] [Full Text] [Related]
49. [Effect of thiophosphamide on the incorporation of H3-thymidine into the DNA of cells of surviving transplantable tumor sections sensitive and resistant toward the agent]. Merkulov MF; Shelaputina ZF; Iavorskaia NP; Leskova SG Farmakol Toksikol; 1971; 34(1):91-7. PubMed ID: 4998192 [No Abstract] [Full Text] [Related]
50. Experimental approach for the search of effective drug combination in cancer chemotherapy. Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556 [TBL] [Abstract][Full Text] [Related]
51. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine. Kataoka T; Akahori Y; Sakurai Y Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896 [TBL] [Abstract][Full Text] [Related]
52. Nucleosides. XXIX. 1-beta-D-arabinofuranosyl-5-fluorocytosine and related arabino nucleosides. Fox JJ; Miller N; Wempen I J Med Chem; 1966 Jan; 9(1):101-5. PubMed ID: 5958936 [No Abstract] [Full Text] [Related]
53. Cancer-suppressive activity of biological fluids. Tanjun T; Ming C Sci Sin; 1979 Jul; 22(7):835-43. PubMed ID: 493923 [No Abstract] [Full Text] [Related]
55. The specificity of inhibition of tumor cell viability by DNA. Glick JL Cancer Res; 1967 Dec; 27(12):2338-41. PubMed ID: 4866763 [No Abstract] [Full Text] [Related]
56. Thymidylate kinase as target enzyme for 5'-deoxythymidine and various 5'-deoxy-5'-halogeno pyrimidine nucleosides. Langen P; Kowollik G; Schütt M; Etzold G Acta Biol Med Ger; 1969; 23(6):Suppl:K 19+. PubMed ID: 5375492 [No Abstract] [Full Text] [Related]
57. [Influence of cyclophosphamide, ribo-azauracil and mercaleukin pretreatment on experimental metastasizing in a syngenic tumor-host system. I. Spontaneous breast carcinoma of the mouse]. Nowak C; Elbe B; Arnold W; Bender E Arch Geschwulstforsch; 1973; 41(1):1-11. PubMed ID: 4700692 [No Abstract] [Full Text] [Related]